To further understand the action of Salidroside treatment in regulating the COPD-related skeletal muscle atrophy, the relative levels of myostatin and myogenin expression in the GN tissue samples were determined by Western blot (Figure 4A). Here, MSTN is linked to chronic obstructive pulmonary disease.